CurAegis (CRGS) 10-K 29 Mar 19 2018 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Mar. 25, 2019	Jun. 30, 2018
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	0001063197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		50,400,545
Entity Public Float			$ 13,528
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current Assets:
Cash	$ 53,000	$ 194,000
Accounts receivable		8,000
Inventory (net)		1,744,000
Prepaid expenses and other current assets	25,000	27,000
Total current assets	78,000	1,973,000
Software (net)	10,000	102,000
Property and equipment (net)	62,000	125,000
Total non-current assets	72,000	227,000
Total Assets	150,000	2,200,000
Current Liabilities:
Accounts payable	323,000	167,000
Liability for inventory held at vendor	1,462,000	1,678,000
Other current liabilities	75,000	110,000
Accrued interest	166,000	87,000
Total current liabilities	2,026,000	2,042,000
Non-current lease obligation		3,000
Senior convertible notes (net)	6,603,000	3,563,000
Total Liabilities	8,629,000	5,608,000
Commitments and other matters (Note 14)
Stockholders' (Deficiency):
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at December 31, 2018 and 2017: 50,364,549 and 48,979,546, respectively	504,000	490,000
Additional paid-in capital	77,725,000	76,494,000
Accumulated deficiency	(87,149,000)	(80,841,000)
Total Stockholders' (Deficiency)	(8,479,000)	(3,408,000)
Total Liabilities and Stockholders' (Deficiency)	150,000	2,200,000
Preferred Class C [Member]
Stockholders' (Deficiency):
Preferred stock, value	157,000	159,000
Series C2 Preferred Stock [Member]
Stockholders' (Deficiency):
Preferred stock, value	245,000	250,000
Series C3 Preferred Stock [Member]
Stockholders' (Deficiency):
Preferred stock, value	33,000	34,000
Preferred Class A [Member]
Stockholders' (Deficiency):
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Stockholders' (Deficiency):
Preferred stock, value	$ 1,000	$ 1,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	50,364,549	48,979,546
Common stock, shares outstanding (in shares)	50,364,549	48,979,546
Preferred Class C [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	15,687,500	15,937,500
Preferred stock, shares outstanding (in shares)	15,687,500	15,937,500
Series C2 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	24,500,000	25,000,000
Preferred stock, shares outstanding (in shares)	24,500,000	25,000,000
Preferred stock, par value (in dollars per share)	$ 0.01
Series C3 Preferred Stock [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0	$ 0
Preferred stock, shares issued (in shares)	3,268,000	3,388,000
Preferred stock, shares outstanding (in shares)	3,268,000	3,388,000
Preferred Class A [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.40	$ 0.40
Preferred stock, shares issued (in shares)	468,221	468,221
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred stock, shares authorized (in shares)	3,300,000
Preferred Class B [Member]
Preferred stock, cumulative dividend per share (in dollars per share)	$ 0.50	$ 0.50
Preferred stock, shares issued (in shares)	67,500	67,500
Preferred stock, shares outstanding (in shares)	67,500	67,500
Preferred stock, shares authorized (in shares)	300,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenue and costs:
CURA revenue	$ 37,000	$ 39,000
Cost of revenue	110,000	161,000
Loss on revenue	(73,000)	(122,000)
Inventory reserve	1,741,000
Impairment loss	17,000	357,000
Engineering and development	1,262,000	1,502,000
General and administrative	2,159,000	2,749,000
Total costs and expenses	5,179,000	4,608,000
Loss from operations	(5,252,000)	(4,730,000)
Interest expense	(1,057,000)	(765,000)
Gain on extinguishment of debt		70,000
Other income	1,000	2,000
	(1,056,000)	(693,000)
Loss before income taxes	(6,308,000)	(5,423,000)
Income taxes
Net loss	(6,308,000)	(5,423,000)
Preferred stock dividends	218,000	248,000
Net loss attributable to common stockholders	$ (6,526,000)	$ (5,671,000)
Net loss per share attributable to common stockholders
Basic and Diluted (in dollars per share)	$ (0.13)	$ (0.12)
Weighted average number of shares of common stock
Basic and Diluted (in shares)	49,781,000	48,032,000

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' (Deficit) - USD ($)	Conversion of Preferred A to Common Shares [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Preferred A to Common Shares [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Preferred A to Common Shares [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Preferred A to Common Shares [Member]Preferred Stock [Member]Preferred Class A [Member]	Conversion of Preferred A to Common Shares [Member]Preferred Stock [Member]Preferred Class B [Member]	Conversion of Preferred A to Common Shares [Member]Common Stock [Member]	Conversion of Preferred A to Common Shares [Member]Additional Paid-in Capital [Member]	Conversion of Preferred A to Common Shares [Member]Retained Earnings [Member]	Conversion of Preferred A to Common Shares [Member]	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Preferred Class A [Member]	Conversion of Preferred C to Common Share [Member]Preferred Stock [Member]Preferred Class B [Member]	Conversion of Preferred C to Common Share [Member]Common Stock [Member]	Conversion of Preferred C to Common Share [Member]Additional Paid-in Capital [Member]	Conversion of Preferred C to Common Share [Member]Retained Earnings [Member]	Conversion of Preferred C to Common Share [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Preferred Class A [Member]	Conversion of Preferred C3 to Common Stock [Member]Preferred Stock [Member]Preferred Class B [Member]	Conversion of Preferred C3 to Common Stock [Member]Common Stock [Member]	Conversion of Preferred C3 to Common Stock [Member]Additional Paid-in Capital [Member]	Conversion of Preferred C3 to Common Stock [Member]Retained Earnings [Member]	Conversion of Preferred C3 to Common Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Preferred Class A [Member]	Conversion of Preferred C2 to Common Stock [Member]Preferred Stock [Member]Preferred Class B [Member]	Conversion of Preferred C2 to Common Stock [Member]Common Stock [Member]	Conversion of Preferred C2 to Common Stock [Member]Additional Paid-in Capital [Member]	Conversion of Preferred C2 to Common Stock [Member]Retained Earnings [Member]	Conversion of Preferred C2 to Common Stock [Member]	Conversion of Convertible Notes for Common Stock [Member]Preferred Stock [Member]Series C Preferred Stock [Member]	Conversion of Convertible Notes for Common Stock [Member]Preferred Stock [Member]Series C2 Preferred Stock [Member]	Conversion of Convertible Notes for Common Stock [Member]Preferred Stock [Member]Series C3 Preferred Stock [Member]	Conversion of Convertible Notes for Common Stock [Member]Preferred Stock [Member]Preferred Class A [Member]	Conversion of Convertible Notes for Common Stock [Member]Preferred Stock [Member]Preferred Class B [Member]	Conversion of Convertible Notes for Common Stock [Member]Common Stock [Member]	Conversion of Convertible Notes for Common Stock [Member]Additional Paid-in Capital [Member]	Conversion of Convertible Notes for Common Stock [Member]Retained Earnings [Member]	Conversion of Convertible Notes for Common Stock [Member]	Preferred Stock [Member]Series C Preferred Stock [Member]	Preferred Stock [Member]Series C2 Preferred Stock [Member]	Preferred Stock [Member]Series C3 Preferred Stock [Member]	Preferred Stock [Member]Preferred Class A [Member]	Preferred Stock [Member]Preferred Class B [Member]	Common Stock [Member]Preferred Class A [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Series C2 Preferred Stock [Member]	Series C3 Preferred Stock [Member]	Preferred Class A [Member]	Total
Balance (in shares) at Dec. 31, 2016																																														16,000,000	25,000,000	5,022,000	543,221	67,500		47,066,765
Balance at Dec. 31, 2016																																														$ 160,000	$ 250,000	$ 50,000	$ 5,000	$ 1,000		$ 470,000	$ 76,065,000	$ (75,418,000)				$ 1,583,000
Conversion Preferred to common shares (in shares)				(75,000)		75,000				(62,500)					62,500						(1,634,000)			1,634,000																											75,000	1,634,000					0	1,872,781
Conversion Preferred to common shares						$ 1,000			$ 1,000	$ (1,000)					$ 1,000						$ (16,000)			$ 16,000
Preferred A dividends paid in common shares (in shares)																																																			101,281	101,281
Preferred A dividends paid in common shares																																																				$ 1,000	(1,000)
Exercise common stock warrant (in shares)																																																				40,000
Exercise common stock warrant																																																				$ 1,000	9,000					10,000
Stock-based compensation																																																					159,000					159,000
Issuance of warrants with convertible note																																																					262,000					262,000
Net Loss																																																						(5,423,000)				(5,423,000)
Balance (in shares) at Dec. 31, 2017																																														15,937,500	25,000,000	3,388,000	468,221	67,500		48,979,546
Balance at Dec. 31, 2017																																														$ 159,000	$ 250,000	$ 34,000	$ 5,000	$ 1,000		$ 490,000	76,494,000	(80,841,000)				$ (3,408,000)
Conversion Preferred to common shares (in shares)										(250,000)					250,000						(120,000)			120,000					(500,000)				500,000									190,150													500,000	120,000		874,000
Conversion Preferred to common shares										$ (2,000)					$ 2,000						$ (1,000)			$ 1,000					$ (5,000)				$ 5,000									$ 2,000	$ 47,000		$ 49,000
Exercise common stock warrant (in shares)																																																				4,000
Exercise common stock warrant																																																				$ 1,000	1,000					$ 2,000
Stock-based compensation																																																					180,000					180,000
Issuance of warrants with convertible note																																																					557,000					557,000
Net Loss																																																						(6,308,000)				(6,308,000)
Beneficial conversion feature on convertible note																																																					369,000					369,000
Common shares issued for interest (in shares)																																																				320,853
Common shares issued for interest																																																				$ 3,000	77,000					80,000
Balance (in shares) at Dec. 31, 2018																																														15,687,500	24,500,000	3,268,000	468,221	67,500		50,364,549
Balance at Dec. 31, 2018																																														$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000		$ 504,000	$ 77,725,000	$ (87,149,000)				$ (8,479,000)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net loss	$ (6,308,000)	$ (5,423,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	138,000	180,000
Amortization of discount reported as interest	627,000	535,000
Stock-based compensation	180,000	159,000
Inventory reserve	1,741,000
Impairment loss	17,000	357,000
Interest paid in shares	81,000
Gain on extinguishment of debt		(70,000)
Changes in working capital items:
Accounts receivable	8,000	2,000
Inventory		(1,720,000)
Prepaid expenses and other current assets	2,000	21,000
Accounts payable and other current liabilities	(16,000)	1,737,000
Net cash used in operating activities	(3,530,000)	(4,222,000)
Cash flows from investing activities:
Purchase of software, property and equipment		(420,000)
Net cash used in investing activities		(420,000)
Cash flows from financing activities:
Proceeds from issuance of senior convertible note (net)	3,388,000	2,817,000
Proceeds from exercise of common stock warrant	1,000	10,000
Repayment of capital lease obligation
Net cash provided by financing activities	3,389,000	2,827,000
Net (decrease) in cash	(141,000)	(1,815,000)
Cash at beginning of year	194,000	2,009,000
Cash at end of year	53,000	194,000
Supplemental Disclosures:
Cash used for payment of interest expense	271,000	172,000
Debt discount related to warrants and beneficial conversion feature	933,000	262,000
Common shares issued in payment of interest expense	80,000
Common shares issued upon conversion of debt	49,000
Conversion of preferred shares to common	8,000	18,000
Conversion of preferred dividends to common		$ 405,000

Note 1 - The Company and Basis

Note 1 - The Company and Basis of Presentation	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the CURA System) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not The Company has created the CURA System to market products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of the following capabilities: ● real-time alertness utilizing the CURA app, ● the Group Wellness Index and ● the Z-Coach wellness program. The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be: ● smaller, lighter and less expensive than conventional pumps and motors, ● more efficient, ● as reliable, and ● unique in its ability to scale larger, allowing more powerful pumps and motors. It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of December 31, 2018, $53,000, $1,948,000, $8,479,000 $87,149,000. December 31, 2018 $3,388,000 Management estimates that the 2019 $3 $3.5 fourth 2018. December 31, 2018, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may not The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA division; (ii) generate revenue from the licensing or sale of our hydraulic technologies or; (iii) decrease engineering and development and administrative expenses. If these and other factors are not no

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Significant Accounting Policies [Text Block]	NOTE 2 Consolidation: 56% December 31, 2018, Use of Estimates: Reclassifications: may Cash: may $15,000. Inventory December 31, 2018 $1,747,000. December 31, 2017, $6,000 Accounts Receivable not zero December 31, 2018 December 31, 2017. Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the years ended December 31, 2018 2017 $138,000 $180,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may During the year ended December 31, 2018 $17,000 December 31, 2017 $357,000 Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 December 31, 2018 2017. $6,134,000 December 31, 2018 December 31, 2018. Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the year ended December 31, 2018 $26,000 $11,000. 78% December 31, 2018. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 93% 2018. Engineering and Development and Patents: December 31, 2018 2017 $150,000 $146,000, Stock-based Compensation: 718 10 may 718 10. No During 2018, 2018 07, 718 20 January 1, 2018 $10,000 Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not December 31, 2018, December 31, 2017, no In 2016, 2016 09, 718 first 2017 $1,684,000 no Loss per Common Share: 260 10 December 31, 2018 2017, 94,784,206 80,288,000 625,000 December 31, 2018 2017 not Recent Accounting Pronouncements: February 25, 2016, No. 2016 02, December 15, 2018, December 31, 2018 $224,000

Note 3 - Inventory and Related

Note 3 - Inventory and Related Vendor Liability	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Inventory Disclosure [Text Block]	NOTE 3 The Company had the following inventory held at our manufacturing vendor and on hand as of December 31, 2018 2017: December 31, 2018 2017 Raw materials $ 1,678,000 $ 1,681,000 Finished goods 69,000 69,000 1,747,000 1,750,000 Less: Reserve (1,747,000 ) (6,000 ) Inventory (net) $ - $ 1,744,000 Liability for inventory held at vendor $ 1,462,000 $ 1,678,000 During 2017, third December 31, 2018, $1,678,000 $1,462,000 During the third 2018, $1,741,000

Note 4 - Senior Convertible Not

Note 4 - Senior Convertible Notes and Warrants	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	NOTE 4 - SENIOR CONVERTIBLE NOTES AND WARRANTS At December 31, 2018, $9,160,000 $2,557,000, $6,603,000. December 31, 2017, $5,825,000 $2,262,000 $3,563,000. none twelve December 31, 2019 2020, $2,990,000 2021, $2,775,000 2022 $3,395,000 2023. As of December 31, 2018, $2,252,500 six $1,170,000 Total JULY 2018 Convertible Notes 2018 Convertible Notes 2017 6% Convertible Notes 2016 6% Convertible Notes Face value December 31, 2017 $ 5,825,000 $ - $ - $ 2,825,000 $ 3,000,000 Notes issued in 2018 (gross) 3,395,000 1,175,000 625,000 1,595,000 - Notes converted in 2018 (60,000 ) - - (50,000 ) (10,000 ) Face value December 31, 2018 $ 9,160,000 $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2017 $ (2,262,000 ) $ - $ - $ (261,000 ) $ (2,001,000 ) Debt discount on notes issued 2018 (933,000 ) (380,000 ) (250,000 ) (303,000 ) - Amortization of discount reported as interest 627,000 20,000 19,000 105,000 483,000 Debt converted in 2018 (net) 11,000 - - 3,000 8,000 Debt discount December 31, 2018 $ (2,557,000 ) $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Senior Convertible Notes (net) $ 6,603,000 $ 815,000 $ 394,000 $ 3,914,000 $ 1,480,000 JULY 2018 On July 19, 2018, $2.5 “JULY 2018 July 24, 2018 “JULY 2018 JULY 2018 five The conversion rate of the notes was fixed at $0.25 July 24, 2018. $500,000 10% $500,000 25% $0.25 ten 4 2 1933 506 501 During the year ended December 31, 2018, $1,175,000 JULY 2018 590,000 $0.25 10 $3,000 2018 2015 03 835 30 five JULY 2018 The Company allocated $380,000 JULY 2018 December 31, 2018, $20,000 2018 On May 8, 2018, $1 “2018 May 8, 2018 “2018 2018 five July 19, 2018, July 19, 2018, 2018 $625,000 460,000 The conversion rate of the notes was fixed at $0.25 May 8, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 The Company incurred approximately $4,000 2018 2015 03 835 30 five $250,000 2018 During the year ended December 31, 2018 $19,000 2017 The board of directors authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 July 19, 2018, 2017 $4,420,000 2,307,207 The 2017 five 6%. first Investors making investments of less than $500,000 10% $500,000 25% The conversion rate of the notes was originally fixed at $0.50 May 31, 2017 November 30, 2017 $0.333 $0.50 ten November 30, 2017 $0.333 $2,450,000 fourth 2017, $0.333 2017 2017. The 2017 4 2 506 501 The Company issued $1,595,000 2017 December 31, 2018 4,789,790 1,120,871 $303,000 During the year ended December 31, 2018, $355,000 $105,000 December 31, 2017, $128,000 $79,000 2016 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. first The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. The Company allocated $2,551,000 2016 2016 1,200,000 $0.25 10 $28,000 2016 2015 03 835 30 five 2016 During the year ended December 31, 2018, $664,000 $483,000. December 31, 2017 $636,000 $456,000.

Note 5 - Capital Lease Obligati

Note 5 - Capital Lease Obligation	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Capital Leases in Financial Statements of Lessee Disclosure [Text Block]	NOTE 5 In 2015, 5 $9,000 $170 5.3%. $2,000 2020.

Note 6 - Software

Note 6 - Software	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 6 The Company investments in software for the CURA are amortized over an estimated useful life of 3 December 31, 2018 2017 $92,000 $125,000, December 31, 2018 2017 $10,000 $102,000, $10,000 2019. During the year ended December 31, 2017 $357,000

Note 7 - Property and Equipment

Note 7 - Property and Equipment	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	NOTE 7 At December 31, 2018 2017 December 31, 2018 December 31, 2017 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 231,000 Leasehold improvements 253,000 253,000 684,000 733,000 Less accumulated depreciation (622,000 ) (608,000 ) Net property and equipment $ 62,000 $ 125,000 Depreciation expense for the years ended December 31, 2018 2017 $46,000 $55,000

Note 8 - Business Segments

Note 8 - Business Segments	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	NOTE 8 The Company has two Segment information for the year ended December 31, 201 8 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 37,000 $ - $ - $ 37,000 Loss on revenue 73,000 - - 73,000 Inventory reserve 1,741,000 - - 1,741,000 Impairment loss 17,000 - - 17,000 Total costs and expenses 1,324,000 658,000 1,439,000 3,421,000 Loss from operations 3,082,000 658,000 1,439,000 5,179,000 Other expense - - 1,056,000 1,056,000 Net loss $ 3,155,000 $ 658,000 $ 2,495,000 $ 6,308,000 Stock based compensation $ 1,000 $ 44,000 $ 135,000 $ 180,000 Depreciation and amortization $ 110,000 $ 20,000 $ 8,000 $ 138,000 Capital expenditures $ - $ - $ - $ - Assets at December 31, 2018 $ 15,000 $ 54,000 $ 81,000 $ 150,000 Segment information for the year ended December 31, 201 7 for the Company’s business segments follows: CURA Aegis Corporate Total Revenue $ 39,000 $ - $ - $ 39,000 Loss on revenue 122,000 - - 122,000 Impairment loss 357,000 - - 357,000 Total costs and expenses 2,608,000 516,000 1,484,000 4,608,000 Loss from operations 2,730,000 516,000 1,484,000 4,730,000 Other expense (income) - - 693,000 693,000 Net loss $ 2,730,000 $ 516,000 $ 2,177,000 $ 5,423,000 Stock based compensation $ 55,000 $ 7,000 $ 97,000 $ 159,000 Depreciation and amortization $ 150,000 $ 18,000 $ 12,000 $ 180,000 Capital expenditures $ 373,000 $ 47,000 $ - $ 420,000 Assets at December 31, 2017 $ 1,894,000 $ 75,000 $ 231,000 $ 2,200,000

Note 9 - Income Taxes

Note 9 - Income Taxes	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	NOTE 9 We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not not The provision (benefit) for income taxes for the years ended December 31, 2018 2017 2018 2017 Current tax expense (benefit): Federal $ - $ - State - - Deferred tax expense (benefit): Federal 1,093,000 5,418,000 State 252,000 127,000 Change in valuation allowance (1,345,000 ) (5,545,000 ) Provision for income tax $ - $ - The difference between income taxes at the statutory federal income tax rate and income taxes reported in the statements of operations for each of the years ended December 31, 2017 2018 2018 2017 Income tax benefit at federal statutory rate $ (1,325,000 ) $ (1,846,000 ) State income tax (benefit), net of federal taxes (199,000 ) (84,000 ) Non-deductible debt discount 132,000 182,000 Expiration of warrants - 221,000 Change in tax rate - 6,869,000 Other 47,000 35,000 Increase (decrease) in valuation allowance 1,345,000 (5,545,000 ) Provision for income taxes $ - $ - The deferred tax asset at December 31, 2018 2017 2018 2017 Deferred income tax assets: Net operating loss carryforwards $ 3,044,000 $ 2,604,000 Deferred startup costs 10,787,000 9,853,000 Stock-based compensation 1,302,000 1,294,000 Other 117,000 153,000 15,250,000 13,904,000 Less: Valuation allowance (15,250,000 ) (13,904,000 ) Net deferred tax asset $ - $ - Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. During the year ended December 31, 2017, 21%. December 31, 2017. On December 22, 2017, not 1 35 21 2 3 December 31, 2017; ( 4 December 31, 2017; 5 On December 22, 2017, No. 118 not December 31, 2017. December 31, 2018, The deferred U.S. income tax expense for 2017 one $6,869,000 zero The Tax Act limits net operating loss deductions to 80% 2017. may 2018, $1,309,000, At December 31, 2018, $11,896,000 $11,187,000 2023 2037. December 31, 2018, 80% $200,000 2037. 2018, $41,690,000 15 The amortization period for a nominal portion of the startup expenses, $273,000, 195 2018 2018 2018 no 2018 195 195 15 Effective January 1, 2017, 2016 09, 718 $1,684,000 no Based upon the change in ownership rules under Section 382 1986, 50% three may may 382 may Reconciliations of the beginning and ending amounts of unrecognized tax benefits for the years ended December 31, 2018 2017 2018 2017 Balance as of January 1 $ 1,112,000 $ 1,684,000 Reductions based on enacted change in tax rates - (572,000 ) Balance as of December 31 $ 1,112,000 $ 1,112,000 Tax years that remain subject to examination for our major tax jurisdictions include the years ended December 31, 2015 December 31, 2018. may

Note 10 - Preferred and Common

Note 10 - Preferred and Common Stock	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 10 Common Stock We have authorized 400,000,000 $0.01 During the year ended December 31, 2018, 874,000 320,853 $0.25 2016 2017 190,150 $0.25 During the year ended December 31, 2017, 1,872,781 40,000 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 may Class A Preferred Stock 3,300,000 one one no The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $.40 1 $4.00 not may one one may not may, $4.00 During the year ended December 31, 2017, 75,000 one 101,281 No 2018. At December 31, 2018, 468,221 8,709 no 468,221 $2,530,000 $2,346,000 December 31, 2018 2017, In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders’ liquidation preference was approximately $2,530,000 $2,346,000 December 31, 2018 2017, 1 $4.00 Class B Preferred Stock 300,000 Each Class B Preferred Share is convertible after a one one one no Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative dividends in the amount of $.50 1 $5.00 not may one one not may, $5.00 Depending upon our cash position, from time to time we may December 31, 2018 2017, no At December 31, 2018, 67,500 $454,000. $454,000 $420,000 December 31, 2018 2017, 1 $5.00 Series C Preferred Stock 16,250,000 one The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no During the years ended December 31, 2018 2017, 250,000 62,500 December 31, 2018 2017, 15,687,500 15,937,500, $6,275,000 $6,375,000 December 31, 2018 2017, Series C- 2 Preferred Stock March 2014, 25,000,000 2 Each Series C- 2 one $0.01 The Series C- 2 $0.20 two 2 fifty fifty The Series C- 2 not no 2 We may not, two 2 2 2 2 2 2 2 2 not The Series C- 2 not 1933, may not During 2018, 2 500,000 2 December 31, 2018 2017, 24,500,000 25,000,000 2 2 $4,900,000 $5,000,000 December 31, 2018 2017. In connection with the issuance of the Series C- 2 September 23, 2011 3, three 144. $500,000 one twelve first Pursuant to the terms of the Investors’ Rights Agreement, the Company may not $1,000,000 third The Investors also agreed to “Market Stand-off” provisions that may may 3,000,000 Series C- 3 Preferred Stock 2015, 2 10,000,000 3 In 2015, $2,500,000 3 $0.25 506 1933. 501 1933. 3 one The Series C- 3 pari passu 2 3 not no 3 The Series C- 3 not 1933. 144 1933 may not 1933 During the year ended December 31, 2018, 120,000 3 December 31, 2017, 1,634,000 3

Note 11 - Stock Options

Note 11 - Stock Options	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 11 2016 Stock Option Plan 2016 “2016 3,000,000 may 2016 December 31, 2018, 1,220,000 2011 Stock Option Plan 2011 “2011 3,000,000 may 2011 Under the 2016 2011 may may may not 10% may not 110% ten 10% may not five During the year ended December 31, 2018, 1,787,500 $0.23 $0.35 10 three four The expense recognized for options that are granted to consultants (i.e., non-employees) reflect fair value, based on updated valuation assumptions using the Black-Scholes valuation model at each measurement period. Such expense is apportioned over the requisite service period of the consultant, which is concurrent with the vesting dates of the various tranches. Non-Plan Options Summary December 31, 2018 2017, $180,000 $159,000, December 31, 2018, $297,000 1.1 The weighted average grant date fair value of stock options granted during the years ended December 31, 2018 2017 $0.23 $0.76, December 31, 2018 2017 $412,000 $173,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2018 2017 Expected term (years) 5.4 6.6 Expected forfeiture rate 0% 0% Risk-free rate 2.8% 2.1% Volatility 137% 130% Dividend yield 0.0% 0.0% The average risk-free interest rate is based on the U.S. Treasury Security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of all of our outstanding stock options for the years ended December 31, 2018 2017: Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2017 9,447,000 $ 0.53 4.8 $ 2,016,000 Granted 235,000 0.76 Exercised - - Canceled or expired - - Outstanding at December 31, 2017 9,682,000 0.54 3.9 $ 114,000 Granted 1,787,500 0.27 Exercised - - Canceled or expired 441,000 0.54 Outstanding at December 31, 2018 11,028,500 $ 0.49 3.8 $ 94,000 Exercisable at December 31, 2018 7,012,250 $ 0.58 2.9 $ 1,000 During the year ended December 31, 2018, no 441,000 No December 31, 2017. December 31, 2018, 2,908,500 2011 1,992,250 91,500 2011 December 31, 2018, 1,220,000 2016 270,000 1,780,000 2016 As of December 31, 2018, $.22 $1.58

Note 12 - Warrants

Note 12 - Warrants	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Stockholders Equity Note Warrants Or Rights [Text Block]	NOTE 12 The following summarizes the activity of our outstanding warrants for the years ended December 31, 2018 2017: Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2017 4,218,500 $ 0.95 (A) 6.1 (B) $ 874,000 Granted 1,186,336 0.33 Exercised (40,000 ) 0.20 Canceled or expired (150,000 ) 5.00 Outstanding at December 31, 2017 5,214,836 0.57 (A) 6.5 (B) $ 103,000 Granted 2,170,871 0.29 Exercised (4,000 ) 0.25 Canceled or expired - - Outstanding at December 31, 2018 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Exercisable at December 31, 2018 6,756,707 $ 0.45 6.5 (C) $ 39,000 (A) The weighted average exercise price for warrants outstanding as of December 31, 2018 2017 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of December 31, 2018 2017 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of December 31, 2018, 2017 118,500 no

Note 13 - Related Party Transac

Note 13 - Related Party Transactions	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 13 As of December 31, 2018, $2,252,500 six 7,888,378 1,239,285 December 31, 2018 $33,000. We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. (See Note 14.

Note 14 - Commitments and Other

Note 14 - Commitments and Other Matters	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	NOTE 14 Leases We occupy a leased facility for our corporate headquarters building, located in Rochester, New York, which consists of both executive offices and manufacturing space. The facility is owned by a partnership in which a Company director is associated. The current rental rate is $6,825 $81,900 May 2019 two one Rent expense for each of the years ended December 31, 2018 2017 $80,000 December 31, 2019 $34,000. 401 : 401 401 may, not 2018 2017, $2,000 401

Note 15 - Subsequent Events

Note 15 - Subsequent Events	12 Months Ended
	Dec. 31, 2018
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 15 JULY 201 8 Convertible Notes Subsequent to December 31, 2018, $450,000 JULY 2018 330,000 Related Party Note date January 23, 2019 On January 23, 2019, $100,000 90 6%. Common shares Issued in Payment of Interest Expense Subsequent to December 31, 2018, 35,996 $9,000 Director Resignation On March 27, 2019, 8:00 March 27, 2019. not

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Consolidation: 56% December 31, 2018,
Use of Estimates, Policy [Policy Text Block]	Use of Estimates:
Reclassification, Policy [Policy Text Block]	Reclassifications: may
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash: may $15,000.
Inventory, Policy [Policy Text Block]	Inventory December 31, 2018 $1,747,000. December 31, 2017, $6,000
Receivables, Policy [Policy Text Block]	Accounts Receivable not zero December 31, 2018 December 31, 2017.
Software Property And Equipment [Policy Text Block]	Software, Property and Equipment: Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term Depreciation and amortization are computed using the straight-line method. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). Depreciation and software amortization expense for the years ended December 31, 2018 2017 $138,000 $180,000, Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may During the year ended December 31, 2018 $17,000 December 31, 2017 $357,000
Fair Value Measurement, Policy [Policy Text Block]	Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 December 31, 2018 2017. $6,134,000 December 31, 2018 December 31, 2018.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition and Deferred Revenue: January 1, 2018, 606, no 606. not not two The Company's net revenue is derived primarily from domestic customers. For the year ended December 31, 2018 $26,000 $11,000. 78% December 31, 2018. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve 30 93% 2018.
In Process Research and Development, Policy [Policy Text Block]	Engineering and Development and Patents: December 31, 2018 2017 $150,000 $146,000,
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-based Compensation: 718 10 may 718 10. No During 2018, 2018 07, 718 20 January 1, 2018 $10,000
Income Tax, Policy [Policy Text Block]	Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not December 31, 2018, December 31, 2017, no In 2016, 2016 09, 718 first 2017 $1,684,000 no
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share: 260 10 December 31, 2018 2017, 94,784,206 80,288,000 625,000 December 31, 2018 2017 not
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements: February 25, 2016, No. 2016 02, December 15, 2018, December 31, 2018 $224,000

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Software, Property and Equipment Estimated Useful Life [Table Text Block]	Software (in years) 3 Office equipment (in years) 5 - 7 Leasehold improvements lesser of useful life or lease term

Note 3 - Inventory and Relate_2

Note 3 - Inventory and Related Vendor Liability (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2018 2017 Raw materials $ 1,678,000 $ 1,681,000 Finished goods 69,000 69,000 1,747,000 1,750,000 Less: Reserve (1,747,000 ) (6,000 ) Inventory (net) $ - $ 1,744,000 Liability for inventory held at vendor $ 1,462,000 $ 1,678,000

Note 4 - Senior Convertible N_2

Note 4 - Senior Convertible Notes and Warrants (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Convertible Debt [Table Text Block]	Total JULY 2018 Convertible Notes 2018 Convertible Notes 2017 6% Convertible Notes 2016 6% Convertible Notes Face value December 31, 2017 $ 5,825,000 $ - $ - $ 2,825,000 $ 3,000,000 Notes issued in 2018 (gross) 3,395,000 1,175,000 625,000 1,595,000 - Notes converted in 2018 (60,000 ) - - (50,000 ) (10,000 ) Face value December 31, 2018 $ 9,160,000 $ 1,175,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2017 $ (2,262,000 ) $ - $ - $ (261,000 ) $ (2,001,000 ) Debt discount on notes issued 2018 (933,000 ) (380,000 ) (250,000 ) (303,000 ) - Amortization of discount reported as interest 627,000 20,000 19,000 105,000 483,000 Debt converted in 2018 (net) 11,000 - - 3,000 8,000 Debt discount December 31, 2018 $ (2,557,000 ) $ (360,000 ) $ (231,000 ) $ (456,000 ) $ (1,510,000 ) Senior Convertible Notes (net) $ 6,603,000 $ 815,000 $ 394,000 $ 3,914,000 $ 1,480,000

Note 7 - Property and Equipme_2

Note 7 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Property, Plant and Equipment [Table Text Block]	December 31, 2018 December 31, 2017 Office equipment $ 249,000 $ 249,000 Shop equipment 182,000 231,000 Leasehold improvements 253,000 253,000 684,000 733,000 Less accumulated depreciation (622,000 ) (608,000 ) Net property and equipment $ 62,000 $ 125,000

Note 8 - Business Segments (Tab

Note 8 - Business Segments (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	CURA Aegis Corporate Total Revenue $ 37,000 $ - $ - $ 37,000 Loss on revenue 73,000 - - 73,000 Inventory reserve 1,741,000 - - 1,741,000 Impairment loss 17,000 - - 17,000 Total costs and expenses 1,324,000 658,000 1,439,000 3,421,000 Loss from operations 3,082,000 658,000 1,439,000 5,179,000 Other expense - - 1,056,000 1,056,000 Net loss $ 3,155,000 $ 658,000 $ 2,495,000 $ 6,308,000 Stock based compensation $ 1,000 $ 44,000 $ 135,000 $ 180,000 Depreciation and amortization $ 110,000 $ 20,000 $ 8,000 $ 138,000 Capital expenditures $ - $ - $ - $ - Assets at December 31, 2018 $ 15,000 $ 54,000 $ 81,000 $ 150,000 CURA Aegis Corporate Total Revenue $ 39,000 $ - $ - $ 39,000 Loss on revenue 122,000 - - 122,000 Impairment loss 357,000 - - 357,000 Total costs and expenses 2,608,000 516,000 1,484,000 4,608,000 Loss from operations 2,730,000 516,000 1,484,000 4,730,000 Other expense (income) - - 693,000 693,000 Net loss $ 2,730,000 $ 516,000 $ 2,177,000 $ 5,423,000 Stock based compensation $ 55,000 $ 7,000 $ 97,000 $ 159,000 Depreciation and amortization $ 150,000 $ 18,000 $ 12,000 $ 180,000 Capital expenditures $ 373,000 $ 47,000 $ - $ 420,000 Assets at December 31, 2017 $ 1,894,000 $ 75,000 $ 231,000 $ 2,200,000

Note 9 - Income Taxes (Tables)

Note 9 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2018 2017 Current tax expense (benefit): Federal $ - $ - State - - Deferred tax expense (benefit): Federal 1,093,000 5,418,000 State 252,000 127,000 Change in valuation allowance (1,345,000 ) (5,545,000 ) Provision for income tax $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2018 2017 Income tax benefit at federal statutory rate $ (1,325,000 ) $ (1,846,000 ) State income tax (benefit), net of federal taxes (199,000 ) (84,000 ) Non-deductible debt discount 132,000 182,000 Expiration of warrants - 221,000 Change in tax rate - 6,869,000 Other 47,000 35,000 Increase (decrease) in valuation allowance 1,345,000 (5,545,000 ) Provision for income taxes $ - $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2018 2017 Deferred income tax assets: Net operating loss carryforwards $ 3,044,000 $ 2,604,000 Deferred startup costs 10,787,000 9,853,000 Stock-based compensation 1,302,000 1,294,000 Other 117,000 153,000 15,250,000 13,904,000 Less: Valuation allowance (15,250,000 ) (13,904,000 ) Net deferred tax asset $ - $ -
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	2018 2017 Balance as of January 1 $ 1,112,000 $ 1,684,000 Reductions based on enacted change in tax rates - (572,000 ) Balance as of December 31 $ 1,112,000 $ 1,112,000

Note 11 - Stock Options (Tables

Note 11 - Stock Options (Tables)	12 Months Ended
	Dec. 31, 2018
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2018 2017 Expected term (years) 5.4 6.6 Expected forfeiture rate 0% 0% Risk-free rate 2.8% 2.1% Volatility 137% 130% Dividend yield 0.0% 0.0%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2017 9,447,000 $ 0.53 4.8 $ 2,016,000 Granted 235,000 0.76 Exercised - - Canceled or expired - - Outstanding at December 31, 2017 9,682,000 0.54 3.9 $ 114,000 Granted 1,787,500 0.27 Exercised - - Canceled or expired 441,000 0.54 Outstanding at December 31, 2018 11,028,500 $ 0.49 3.8 $ 94,000 Exercisable at December 31, 2018 7,012,250 $ 0.58 2.9 $ 1,000

Note 12 - Warrants (Tables)

Note 12 - Warrants (Tables)	12 Months Ended
	Dec. 31, 2018
Warrant [Member]
Notes Tables
Share-based Compensation, Activity [Table Text Block]	Weighted Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 1, 2017 4,218,500 $ 0.95 (A) 6.1 (B) $ 874,000 Granted 1,186,336 0.33 Exercised (40,000 ) 0.20 Canceled or expired (150,000 ) 5.00 Outstanding at December 31, 2017 5,214,836 0.57 (A) 6.5 (B) $ 103,000 Granted 2,170,871 0.29 Exercised (4,000 ) 0.25 Canceled or expired - - Outstanding at December 31, 2018 7,381,707 $ 0.46 (A) 7.0 (B) $ 39,000 Exercisable at December 31, 2018 6,756,707 $ 0.45 6.5 (C) $ 39,000

Note 1 - The Company and Basi_2

Note 1 - The Company and Basis of Presentation (Details Textual)	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Number of Operating Segments	2
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 53,000	$ 194,000	$ 2,009,000
Working Capital	(1,948,000)
Stockholders' Equity Attributable to Parent, Ending Balance	(8,479,000)	(3,408,000)	$ 1,583,000
Retained Earnings (Accumulated Deficit), Ending Balance	(87,149,000)	$ (80,841,000)
Proceeds From Convertible Debt, Gross	3,388,000
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	3,000,000
Maximum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	$ 3,500,000

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2018	Dec. 31, 2017
Inventory Valuation Reserves, Ending Balance	$ 1,747,000	$ 1,747,000	$ 6,000
Allowance for Doubtful Accounts Receivable, Current, Ending Balance	0	0	0
Depreciation, Depletion and Amortization, Total		138,000	180,000
Capitalized Computer Software, Impairments		17,000	357,000
Revenue from Contract with Customer, Including Assessed Tax		37,000	39,000
Research and Development Expense, Total		1,262,000	1,502,000
Excess Tax Benefit from Share-based Compensation, Operating Activities		0
Allocated Share-based Compensation Expense, Total		180,000	159,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	0	0	0
Deferred Tax Assets, Gross, Total	15,250,000	15,250,000	$ 13,904,000
Operating Leases, Future Minimum Payments Due, Total	224,000	$ 224,000
Convertible Preferred Stock, Notes, Options, and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		94,784,206	80,288,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		625,000	625,000
Accounting Standards Update 2018-07 [Member] | Employee Stock Option [Member]
Allocated Share-based Compensation Expense, Total	(10,000)
Accounting Standards Update 2016-09 [Member]
Deferred Tax Assets, Gross, Total			$ 1,684,000
Increase (Decrease) in Deferred Income Taxes Assets Due to Uncertain Tax Benefits			(1,684,000)
Patents [Member] | General and Administrative Expense [Member]
Research and Development Expense, Total		$ 150,000	$ 146,000
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period		1 year
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage		78.00%
CURA APP and Devices [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage		93.00%
Transferred over Time [Member]
Revenue from Contract with Customer, Including Assessed Tax		$ 26,000
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Including Assessed Tax		11,000
Senior Convertible Promissory Notes [Member]
Long-term Debt, Fair Value	6,134,000	6,134,000
Commercial Paper [Member] | Collateral Pledged [Member]
Debt Instrument, Collateral Amount	$ 15,000	$ 15,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage	56.00%	56.00%

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Property, and Equipment, Estimated Useful Lives (Details)	12 Months Ended
	Dec. 31, 2018
Office Equipment [Member] | Minimum [Member]
Property plant and equipment, useful lives (Year)	5 years
Office Equipment [Member] | Maximum [Member]
Property plant and equipment, useful lives (Year)	7 years
Leasehold Improvements [Member]
Property plant and equipment, useful lives	lesser of useful life or lease term
Computer Software, Intangible Asset [Member]
Property plant and equipment, useful lives (Year)	3 years

Note 3 - Inventory and Relate_3

Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Inventory, Raw Materials, Gross, Total		$ 1,678,000	$ 1,681,000
Liability for Inventory Held at Vendor		1,462,000	1,678,000
Inventory Write-down	$ 1,741,000	$ 1,741,000

Note 3 - Inventory and Relate_4

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Raw materials	$ 1,678,000	$ 1,681,000
Finished goods	69,000	69,000
	1,747,000	1,750,000
Less: Reserve	(1,747,000)	(6,000)
Inventory (net)		1,744,000
Liability for inventory held at vendor	$ 1,462,000	$ 1,678,000

Note 4 - Senior Convertible N_3

Note 4 - Senior Convertible Notes and Warrants (Details Textual)	Jul. 24, 2018USD ($)$ / shares	May 08, 2018USD ($)$ / shares	Nov. 30, 2017USD ($)$ / shares	May 31, 2017USD ($)$ / shares	Aug. 25, 2016$ / shares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)$ / sharesshares	Jul. 19, 2018USD ($)shares
Long-term Debt, Gross						$ 9,160,000	$ 5,825,000
Debt Instrument, Unamortized Discount, Total						2,557,000	2,262,000
Long-term Debt, Total						6,603,000
Interest Expense, Total						1,057,000	765,000
Amortization of Debt Discount (Premium)						627,000	535,000
Warrants Related to the 2017 Convertible Notes [Member]
Investment Threshold				$ 500,000
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold				10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 0.333	$ 0.50
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes				25.00%
Class of Warrant or Right, Term				10 years
Warrants Related to the 2016 Convertible Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 0.25			$ 0.25
Warrants and Rights Outstanding, Term					10 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares								1,200,000
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes					10.00%
Convertible Notes [Member]
Long-term Debt, Gross						9,160,000	5,825,000
Debt Instrument, Unamortized Discount, Total						2,557,000	2,262,000
Long-term Debt, Total						6,603,000	3,563,000
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months						0
Long-term Debt, Maturities, Repayments of Principal in Year Three						2,990,000
Long-term Debt, Maturities, Repayments of Principal in Year Four						2,775,000
Long-term Debt, Maturities, Repayments of Principal in Year Five						3,395,000
Long-term Debt, Maturities, Repayments of Principal in Year Two						0
Convertible Notes [Member] | Investor [Member]
Long-term Debt, Total						2,252,500
Convertible Notes [Member] | Affiliated Entity [Member]
Long-term Debt, Total						1,170,000
July 2018 Convertible Notes [Member]
Long-term Debt, Gross						1,175,000
Debt Instrument, Unamortized Discount, Total						360,000
Long-term Debt, Total						$ 815,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement	$ 2,500,000
Debt Instrument, Term	5 years					5 years
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.25
Debt Instrument, Face Amount						$ 1,175,000
Debt Instrument, Debt Discount Before Amortization						380,000
Interest Expense, Total						20,000
Amortization of Debt Discount (Premium)						$ 20,000
Warrants Related to July 2018 Convertible Notes [Member]
Investment Threshold	$ 500,000
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold	10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold	25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares	$ 0.25
Warrants and Rights Outstanding, Term	10 years					10 years
Payments of Debt Issuance Costs						$ 3,000
Warrants Related to the 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold		10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold		25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares		$ 0.25				$ 0.25
Warrants and Rights Outstanding, Term		10 years
Class of Warrant or Right, Outstanding | shares						590,000
The 2018 Convertible Notes [Member]
Long-term Debt, Gross						$ 625,000			$ 625,000
Debt Instrument, Unamortized Discount, Total						231,000
Long-term Debt, Total						$ 394,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 1,000,000
Debt Instrument, Term		5 years				5 years
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 0.25
Class of Warrant or Right, Outstanding | shares									460,000
Payments of Debt Issuance Costs						$ 4,000
Debt Instrument, Debt Discount Before Amortization						250,000
Interest Expense, Total						19,000
Amortization of Debt Discount (Premium)						19,000
The 2017 Convertible Notes [Member]
Long-term Debt, Gross						4,370,000	2,825,000		$ 4,420,000
Debt Instrument, Unamortized Discount, Total						456,000	261,000
Long-term Debt, Total						3,914,000
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement						$ 5,000,000
Debt Instrument, Term						5 years
Debt Instrument, Face Amount						$ 1,595,000
Debt Instrument, Debt Discount Before Amortization						303,000
Interest Expense, Total						$ 355,000	128,000
Debt Instrument, Interest Rate, Stated Percentage						6.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares						1,120,871
Convertible Notes, Aggregate Amount Reissued			$ 2,450,000
Debt Instrument, Convertible, Number of Equity Instruments						4,789,790
Amortization of Debt Discount (Premium)						$ 105,000	79,000
Warrants Related to the 2017 Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares									2,307,207
The 2016 Convertible Notes [Member]
Long-term Debt, Gross						2,990,000	3,000,000
Debt Instrument, Unamortized Discount, Total						1,510,000	2,001,000
Long-term Debt, Total						1,480,000
Debt Instrument, Term					5 years			5 years
Debt Instrument, Convertible, Conversion Price | $ / shares					$ 0.25
Interest Expense, Total						664,000	636,000
Debt Instrument, Interest Rate, Stated Percentage								6.00%
Amortization of Debt Discount (Premium)						$ 483,000	$ 456,000
Debt Instrument, Unamortized Discount, Noncurrent								$ 2,551,000
Debt Issuance Costs, Net, Total								28,000
The 2016 Convertible Notes [Member] | Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement								$ 3,000,000

Note 4 - Senior Convertible N_4

Note 4 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Face value	$ 5,825,000
Notes issued in 2018 (gross)	3,395,000
Notes converted in 2018	(60,000)
Face value	9,160,000	$ 5,825,000
Debt discount	(2,262,000)
Debt discount on notes issued 2018	(933,000)
Amortization of discount reported as interest	627,000	535,000
Debt converted in 2018 (net)	11,000
Debt discount	(2,557,000)	(2,262,000)
Senior Convertible Notes (net)	6,603,000
July 2018 Convertible Notes [Member]
Face value
Notes issued in 2018 (gross)	1,175,000
Notes converted in 2018
Face value	1,175,000
Debt discount
Debt discount on notes issued 2018	(380,000)
Amortization of discount reported as interest	20,000
Debt converted in 2018 (net)
Debt discount	(360,000)
Senior Convertible Notes (net)	815,000
The 2018 Convertible Notes [Member]
Face value
Notes issued in 2018 (gross)	625,000
Notes converted in 2018
Face value	625,000
Debt discount
Debt discount on notes issued 2018	(250,000)
Amortization of discount reported as interest	19,000
Debt converted in 2018 (net)
Debt discount	(231,000)
Senior Convertible Notes (net)	394,000
The 2017 Convertible Notes [Member]
Face value	2,825,000
Notes issued in 2018 (gross)	1,595,000
Notes converted in 2018	(50,000)
Face value	4,370,000	2,825,000
Debt discount	(261,000)
Debt discount on notes issued 2018	(303,000)
Amortization of discount reported as interest	105,000	79,000
Debt converted in 2018 (net)	3,000
Debt discount	(456,000)	(261,000)
Senior Convertible Notes (net)	3,914,000
The 2016 Convertible Notes [Member]
Face value	3,000,000
Notes issued in 2018 (gross)
Notes converted in 2018	(10,000)
Face value	2,990,000	3,000,000
Debt discount	(2,001,000)
Debt discount on notes issued 2018
Amortization of discount reported as interest	483,000	456,000
Debt converted in 2018 (net)	8,000
Debt discount	(1,510,000)	$ (2,001,000)
Senior Convertible Notes (net)	$ 1,480,000

Note 5 - Capital Lease Obliga_2

Note 5 - Capital Lease Obligation (Details Textual) - Office Equipment [Member]	12 Months Ended
	Dec. 31, 2015USD ($)
Capita Lease, Term	5 years
Capital Leased Assets, Gross, Total	$ 9,000
Capital Lease, Monthly Payment	$ 170
Debt Instrument, Interest Rate During Period	5.30%
Capital Lease Obligations, Total	$ 2,000

Note 6 - Software (Details Text

Note 6 - Software (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Capitalized Computer Software, Amortization	$ 92,000	$ 125,000
Capitalized Computer Software, Net, Ending Balance	10,000	102,000
Capitalized Computer Software, Impairments	$ 17,000	$ 357,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	$ 10,000

Note 7 - Property and Equipme_3

Note 7 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Depreciation, Total	$ 46,000	$ 55,000

Note 7 - Property and Equipme_4

Note 7 - Property and Equipment - Property and Equipment (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Office equipment	$ 249,000	$ 249,000
Shop equipment	182,000	231,000
Leasehold improvements	253,000	253,000
	684,000	733,000
Less accumulated depreciation	(622,000)	(608,000)
Net property and equipment	$ 62,000	$ 125,000

Note 8 - Business Segments (Det

Note 8 - Business Segments (Details Textual)	12 Months Ended
	Dec. 31, 2018
Number of Operating Segments	2

Note 8 - Business Segments - Op

Note 8 - Business Segments - Operation by Segments (Details) - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Revenue		$ 37,000	$ 39,000
Loss on revenue		73,000	122,000
Inventory reserve	$ 1,741,000	1,741,000
Impairment loss		17,000	357,000
Total costs and expenses		5,179,000	4,608,000
Loss from operations		5,252,000	4,730,000
Other expense (income)		1,056,000	693,000
Net loss		6,308,000	5,423,000
Stock based compensation		180,000	159,000
Depreciation and amortization		138,000	180,000
Capital expenditures			420,000
Assets		150,000	2,200,000
Operating Segments [Member] | CURA Division [Member]
Revenue		37,000	39,000
Loss on revenue		73,000	122,000
Inventory reserve		1,741,000
Impairment loss		17,000	357,000
Total costs and expenses		1,324,000	2,608,000
Loss from operations		3,082,000	2,730,000
Other expense (income)
Net loss		3,155,000	2,730,000
Stock based compensation		1,000	55,000
Depreciation and amortization		110,000	150,000
Capital expenditures			373,000
Assets		15,000	1,894,000
Operating Segments [Member] | Aegis Division [Member]
Revenue
Loss on revenue
Inventory reserve
Impairment loss
Total costs and expenses		658,000	516,000
Loss from operations		658,000	516,000
Other expense (income)
Net loss		658,000	516,000
Stock based compensation		44,000	7,000
Depreciation and amortization		20,000	18,000
Capital expenditures			47,000
Assets		54,000	75,000
Corporate, Non-Segment [Member]
Revenue
Loss on revenue
Inventory reserve
Impairment loss
Total costs and expenses		1,439,000	1,484,000
Loss from operations		1,439,000	1,484,000
Other expense (income)		1,056,000	693,000
Net loss		2,495,000	2,177,000
Stock based compensation		135,000	97,000
Depreciation and amortization		8,000	12,000
Capital expenditures
Assets		$ 81,000	$ 231,000

Note 9 - Income Taxes (Details

Note 9 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	35.00%
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount		$ 6,869,000
Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability		0
Operating Loss Carryforwards Subject to Expiration	1,309,000
Accumulated Deferred Startup Costs	41,690,000
Amortization of Startup Costs	$ 273,000
Amortization Period Of Startup Costs	15 years
Deferred Tax Assets, Gross, Total	$ 15,250,000	13,904,000
Open Tax Year	2015 2016 2017 2018
Accounting Standards Update 2016-09 [Member]
Deferred Tax Assets, Gross, Total		1,684,000
Increase (Decrease) in Deferred Income Taxes Assets Due to Uncertain Tax Benefits		$ (1,684,000)
Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	$ 200,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards, Total	11,896,000
State and Local Jurisdiction [Member] | New York State Division of Taxation and Finance [Member]
Operating Loss Carryforwards, Total	$ 11,187,000

Note 9 - Income Taxes - Provisi

Note 9 - Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Current tax expense (benefit):
Federal
State
Deferred tax expense (benefit):
Federal	1,093,000	5,418,000
State	252,000	127,000
Change in valuation allowance	(1,345,000)	(5,545,000)
Provision for income tax

Note 9 - Income Taxes - Effecti

Note 9 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income tax benefit at federal statutory rate	$ (1,325,000)	$ (1,846,000)
State income tax (benefit), net of federal taxes	(199,000)	(84,000)
Non-deductible debt discount	132,000	182,000
Expiration of warrants		221,000
Change in tax rate		6,869,000
Other	47,000	35,000
Increase (decrease) in valuation allowance	1,345,000	(5,545,000)
Provision for income tax

Note 9 - Income Taxes - Deferre

Note 9 - Income Taxes - Deferred Tax Asset (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Deferred income tax assets:
Net operating loss carryforwards	$ 3,044,000	$ 2,604,000
Deferred startup costs	10,787,000	9,853,000
Stock-based compensation	1,302,000	1,294,000
Other	117,000	153,000
	15,250,000	13,904,000
Less: Valuation allowance	(15,250,000)	(13,904,000)
Net deferred tax asset

Note 9 - Income Taxes - Reconci

Note 9 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Balance as of January 1	$ 1,112,000	$ 1,684,000
Reductions based on enacted change in tax rates		(572,000)
Balance as of December 31	$ 1,112,000	$ 1,112,000

Note 10 - Preferred and Commo_2

Note 10 - Preferred and Common Stock (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2015	Mar. 31, 2014
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Stock Issued During Period, Shares, Conversion of Convertible Securities	874,000	1,872,781
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Investor Rights Agreement, Maximum Indebtedness	$ 1,000,000
Investor Rights Agreement, Minimum Number Shares of Common Stock by Conversion or Exercise of Series C Securities	3,000,000
Preferred Class A [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		0
Preferred stock, shares authorized (in shares)	3,300,000
Convertible Preferred Stock, Holding Period Required for Conversion	1 year
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 0.40
Preferred Stock, Redemption Price Per Share	$ 4
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred Stock, Shares Outstanding, Not Accruing Dividends	8,709
Dividends Payable	$ 2,530,000	$ 2,346,000
Preferred Stock, Liquidation Preference, Value	$ 2,530,000	$ 2,346,000
Preferred Class B [Member]
Preferred stock, shares authorized (in shares)	300,000
Convertible Preferred Stock, Holding Period Required for Conversion	1 year
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 0.50
Preferred Stock, Redemption Price Per Share	$ 5
Preferred stock, shares outstanding (in shares)	67,500	67,500
Dividends Payable	$ 454,000
Preferred Stock, Liquidation Preference, Value	$ 454,000	$ 420,000
Preferred Stock Dividends, Shares	0
Series C Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	16,250,000
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred stock, shares outstanding (in shares)	15,687,500	15,937,500
Preferred Stock, Liquidation Preference, Value	$ 6,275,000	$ 6,375,000
Preferred Stock, Liquidation Preference Per Share	$ 0.40
Conversion of Stock, Shares Converted	250,000	62,500
Series C2 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	500,000
Preferred stock, shares authorized (in shares)				25,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred stock, shares outstanding (in shares)	24,500,000	25,000,000
Preferred Stock, Liquidation Preference, Value	$ 4,900,000	$ 5,000,000
Preferred Stock, Liquidation Preference Per Share	$ 0.20
Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	120,000
Preferred stock, shares authorized (in shares)			10,000,000
Preferred stock, shares outstanding (in shares)	3,268,000	3,388,000
Private Placement Offering Amount			$ 2,500,000
Sale of Stock, Price Per Share			$ 0.25
Common Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		1,634,000
Stock Issued During Period, Warrant Exercsed	4,000	40,000
Common Stock Dividends, Shares		101,281
Common Stock [Member] | Preferred Class A [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		75,000
Common Stock Dividends, Shares		101,281
Common Stock [Member] | Warrants [Member]
Stock Issued During Period, Warrant Exercsed		40,000
The 2016 and 2017 Convertible Note [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	190,150
Stock Issued During Period, Shares, New Issues	320,853
Shares Issued, Price Per Share	$ 0.25

Note 11 - Stock Options (Detail

Note 11 - Stock Options (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2011	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,787,500	235,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.22
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 1.58
Allocated Share-based Compensation Expense, Total	$ 180,000	$ 159,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total	$ 297,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 36 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 0.23	$ 0.76
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	$ 412,000	$ 173,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total	441,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	11,028,500	9,682,000		9,447,000
Stock Option Plan 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized				3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,220,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	1,220,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	270,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	1,780,000
Stock Option Plan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,787,500
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum			10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date			110.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years		10 years
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 0.23
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 0.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	2,908,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	1,992,250
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	91,500
Stock Option Plan 2011 [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Stock Option Plan 2011 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years

Note 11 - Stock Options - Stock

Note 11 - Stock Options - Stock Options Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Expected term (years) (Year)	5 years 146 days	6 years 219 days
Expected forfeiture rate	0.00%	0.00%
Risk-free rate	2.80%	2.10%
Volatility	137.00%	130.00%
Dividend yield	0.00%	0.00%

Note 11 - Stock Options - Share

Note 11 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Outstanding shares (in shares)	9,682,000	9,447,000
Outstanding - weighted average exercise price (in dollars per share)	$ 0.54	$ 0.53
Outstanding - weighted average remaining contractual term (Year)	3 years 292 days	3 years 328 days	4 years 292 days
Outstanding - aggregate intrinsic value	$ 94,000	$ 114,000	$ 2,016,000
Shares, granted (in shares)	1,787,500	235,000
Weighted average exercise price, granted (in dollars per share)	$ 0.27	$ 0.76
Shares, exercised (in shares)	0	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)	441,000	0
Weighted average exercise price, canceled or expired (in dollars per share)	$ 0.54
Outstanding shares (in shares)	11,028,500	9,682,000	9,447,000
outstanding - weighted average exercise price (in dollars per share)	$ 0.49	$ 0.54	$ 0.53
Shares, exercisable (in shares)	7,012,250
Weighted average exercise price, exercisable (in dollars per share)	$ 0.58
Exercisable- weighted average remaining contractual term (Year)	2 years 328 days
Exercisable-aggregate intrinsic value	$ 1,000

Note 12 - Warrants (Details Tex

Note 12 - Warrants (Details Textual) - shares	Dec. 31, 2018	Dec. 31, 2017
Warrants without Expiration Date, Outstanding	743,500	743,500
Warrants without Expiration Date, Exercisable	118,500	118,500
Warrants Not Determined, Exercise Price [Member]
Class of Warrant or Right, Outstanding	1,750,000	1,750,000

Note 12 - Warrants - Summary of

Note 12 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Outstanding shares (in shares)		9,682,000	9,447,000
Outstanding - weighted average exercise price (in dollars per share)		$ 0.54	$ 0.53
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		1,787,500	235,000
Weighted average exercise price, granted (in dollars per share)		$ 0.27	$ 0.76
Shares, exercised (in shares)		0	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)		(441,000)	0
Weighted average exercise price, canceled or expired (in dollars per share)		$ 0.54
Outstanding shares (in shares)		11,028,500	9,682,000	9,447,000
outstanding - weighted average exercise price (in dollars per share)		$ 0.49	$ 0.54	$ 0.53
Shares, exercisable (in shares)		7,012,250
Weighted average exercise price, exercisable (in dollars per share)		$ 0.58
Exercisable - weighted average remaining contractual term (Year)		2 years 328 days
Exercisable - aggregate intrinsic value		$ 1,000
Warrant [Member]
Outstanding shares (in shares)		5,214,836	4,218,500
Outstanding - weighted average exercise price (in dollars per share)	[1]	$ 0.57	$ 0.95
Outstanding - weighted average remaining contractual term (Year)	[2]	7 years	6 years 182 days	6 years 36 days
Outstanding - aggregate intrinsic value		$ 39,000	$ 103,000	$ 874,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		2,170,871	1,186,336
Weighted average exercise price, granted (in dollars per share)		$ 0.29	$ 0.33
Shares, exercised (in shares)		(4,000)	(40,000)
Weighted average exercise price, exercised (in dollars per share)		$ 0.25	$ 0.20
Shares, canceled or expired (in shares)			(150,000)
Weighted average exercise price, canceled or expired (in dollars per share)			$ 5
Outstanding shares (in shares)		7,381,707	5,214,836	4,218,500
outstanding - weighted average exercise price (in dollars per share)	[1]	$ 0.46	$ 0.57	$ 0.95
Shares, exercisable (in shares)		6,756,707
Weighted average exercise price, exercisable (in dollars per share)		$ 0.45
Exercisable - weighted average remaining contractual term (Year)	[3]	6 years 182 days
Exercisable - aggregate intrinsic value		$ 39,000
[1]	The weighted average exercise price for warrants outstanding as of December 31, 2018 and 2017 excludes 1,750,000 warrants in each period with no determined exercise price.
[2]	The weighted average remaining contractual term for warrants outstanding as of December 31, 2018 and 2017 excludes 743,500 warrants with no expiration date.
[3]	The weighted average remaining contractual term for warrants exercisable as of December 31, 2018, and 2017 excludes 118,500 warrants with no expiration date.

Note 13 - Related Party Trans_2

Note 13 - Related Party Transactions (Details Textual) - Six Members of the Board of Directors [Member]	12 Months Ended
	Dec. 31, 2018USD ($)shares
Warrants Related to the 2018 Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares	1,239,285
The 2018 Convertible Notes [Member]
Debt Instrument, Face Amount	$ 2,252,500
Debt Instrument, Convertible, Number of Equity Instruments	7,888,378
Interest Payable	$ 33,000

Note 14 - Commitments and Oth_2

Note 14 - Commitments and Other Matters (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating Leases, Rent Expense, Total	$ 80,000	$ 80,000
Operating Leases, Future Minimum Payments Receivable, Current	34,000
Defined Contribution Plan, Administrative Expense	2,000	$ 2,000
Director [Member]
Monthly Rent Payment under Operating Lease	6,825
Annual Rent Payment under Operating Lease	$ 81,900

Note 15 - Subsequent Events (De

Note 15 - Subsequent Events (Details Textual) - USD ($)	Jan. 23, 2019	Jul. 24, 2018	Mar. 21, 2019	Dec. 31, 2018
Stock Issued During Period, Value, Interest				$ 80,000
Subsequent Event [Member]
Stock Issued During Period, Shares, Interest			35,996
Stock Issued During Period, Value, Interest			$ 9,000
July 2018 Convertible Notes [Member]
Debt Instrument, Face Amount				$ 1,175,000
Debt Instrument, Term		5 years		5 years
July 2018 Convertible Notes [Member] | Subsequent Event [Member]
Debt Instrument, Face Amount			$ 450,000
Class of Warrant or Right, Granted During Period			330,000
Related Party Note [Member] | Subsequent Event [Member] | Chief Executive Officer and Director [Member]
Notes Payable, Related Parties, Current	$ 100,000
Debt Instrument, Term	90 days
Debt Instrument, Interest Rate, Stated Percentage	6.00%